Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.84
Delayed Data
As of May 27
 +0.07 / +1.86%
Today’s Change
2.65
Today|||52-Week Range
6.29
-4.24%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +134.38% increase from the last price of 3.84.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$0.00
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.33%
 
 
 
 
 
 
Growthannually -12.45%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -82.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.